Navigation Links
Solta Medical Reports Third Quarter 2009 Results
Date:11/3/2009

uarter of 2008. The non-GAAP net loss for the quarter excluding these charges was $4.2 million, or $0.09 per share as compared to non-GAAP net income of $0.7 million, or $0.03 per share reported for the third quarter of 2008.

Financial Goals for 2009

The Company updated its financial goals for 2009 as follows:

  • Revenue for the year in the range of $95 million to $98 million
  • Realize up to $25 million in cost synergies as a result of the acquisition of Reliant Technologies, Inc. This represents an increase of $6 million from the originally stated goal in January 2009 of $19 million in cost synergies.
  • Generate positive EBITDA for the full year 2009
  • Achieve a non-GAAP gross margin in the range of 64% to 66% for the full year 2009 excluding non-cash amortization charges and non-cash purchase price related charges.

Non-GAAP Presentation

To supplement the condensed consolidated financial information presented on a GAAP basis, management has provided non-GAAP gross margin, non-GAAP operating income (loss), non-GAAP EBITDA, non-GAAP net income (loss) and non-GAAP earnings (loss) per share measures that exclude the impact of purchase price related charges, severance costs, merger related costs, extraordinary loss on investments, and stock-based compensation expenses, all net of income taxes. The Company believes that these non-GAAP financial measures provide investors with insight into what is used by management to conduct a more meaningful and consistent comparison of the Company's ongoing operating results and trends, compared with historical results. This presentation is also consistent with management's internal use of the measures, which it uses to measure the performance of ongoing operating results, against prior periods and against our internally developed targets. There are limitations in using these non-GAAP financial measures because they are not prepared in accordance
'/>"/>

SOURCE Solta Medical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Solta Medical, Inc. Appoints Jeffrey Nardoci Vice President of Global Marketing
2. Solta Medical to Present at the Maxim Group Growth Conference
3. Solta Medical Launches illumiNATION tour in U.S. and Europe to Introduce New Thermage CPT(TM) and Fraxel re:store(R) Dual Systems
4. Solta Medical Launches New Fraxel re:store(R) Dual Laser System
5. Solta Medical Reports Strong Second Quarter 2009 Results
6. Solta Medical, Inc. Announces Second Quarter 2009 Results Release Date and Conference Call
7. Solta Medical, Inc. Signs Amendment to Expand Its Credit Facility With Silicon Valley Bank
8. Solta Medical, Inc. to Present at 8th Annual Needham Life Sciences Conference
9. Solta Medical Receives Regulatory Approval to Market Thermage Systems in China
10. Solta Medical, Inc. Announces First Quarter 2009 Results Release Date and Conference Call
11. Solta Medical Presents Expert Roundtable about Thermage(R) and Fraxel(R) Combination Treatments at ASLMS Annual Meeting

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2009)... the amount of television viewed by many young chi...estimates of early childhood screen time, with tho...ore on average than those in center-based daycares...in child care settings in more than 20 years. The...programs in four states, and was guided by lead re...
(Date:11/22/2009)... The Onder Law Firm’s attorneys are ...ilies of those who may have experienced heart atta...taking XOLAIR. , St. Loui...irm are among attorneys offering free XOLAIR case... attack and stroke. The attorneys of the Onder La...
(Date:11/22/2009)....C. November 18, 2009 -- When people have malaria,...h enter the body from the saliva of a mosquito, in...ood cells. Inside the blood cells, the parasites r...s on the cell surface that change the physical nat...ts show that infected red blood cells are stiffer ...
(Date:11/22/2009)...22 2009) -- Physician-scientists from Weill Cornel...anism that may prove to be a powerful target for t...cancer that affects lymphocytes, or white blood ce...e been able to powerfully suppress tumor formation...g results have led to the design of a clinical tri...
(Date:11/22/2009)...n help keep eating under control, expert says , ...holiday season means you,ll be faced with a seemin...people simply give in and eat too much, others den...e ways to navigate between overindulgence and depr...trition Consult Services at Brigham and Women,s Ho...
Breaking Medicine News(10 mins):Health News:Daycare may double TV time for young children, study finds 2Health News:Daycare may double TV time for young children, study finds 3Health News:Daycare may double TV time for young children, study finds 4Health News:The Attorneys of The Onder Law Firm Offers Free XOLAIR Case Review 2Health News:Measuring and modeling blood flow in malaria 2Health News:New cancer target for non-Hodgkin's lymphoma 2Health News:Go Healthy, Not Hungry for Holiday Eating 2
...ndustry Veteran Further Strengthens Company,s Sale...Synetics(TM), the largest,provider of business ser...e, has named Stuart Collins as director, eastern r...,OrthoSynetics(TM). "He will help us grow the comp...
...ATON ROUGE, La., Oct. 18 Edward Clarke of Lohengr...ed a new strategic,partnership with Global Medical... the south Louisiana area. This partnership allow...nd American citizens traveling abroad. Health,insu...
...igher BMI -- Greater Interest in Liposuction, ARL...ith low self-esteem have plastic surgery? Think ag... has no influence on whether a person is,intereste...al of the American Society of Plastic Surgeons (AS...
...L Solutions launches new version of Infection Surv... software., TORONTO, Oct. 18 /PRNewswire/ - rL So...y and safety software, today announced the release...vention Week (IIPW), running from October,14th to ...
...ENVER, Oct. 18 Global Med Technologies(R),Inc. (O...h, medical,information technology company, announc...n ("Wyndgate") has submitted its ElDorado Donor(TM...,clearance by the FDA. ElDorado Donor is intended...
... WASHINGTON -- Many people, including significant... veterans, suffer from post-traumatic stress disor...es or illnesses. While several drugs and psychoth...what works and what doesn,t, says a new report fro...
Other Medicine News:Health News:Lohengrin Group Announces Bold New Product Line 2Health News:Body Image Has Little Influence on Desire for Plastic Surgery, ASPS Study Reveals 2Health News:Body Image Has Little Influence on Desire for Plastic Surgery, ASPS Study Reveals 3Health News:Infection MonitorPro Version 1.1 Released during International Infection Prevention Week 2Health News:Global Med Technologies(R), Inc. Submits ElDorado Donor(TM) to FDA 2Health News:Global Med Technologies(R), Inc. Submits ElDorado Donor(TM) to FDA 3Health News:Effectiveness of most PTSD therapies is uncertain 2Health News:Effectiveness of most PTSD therapies is uncertain 3
(Date:11/23/2009)...cedSterilizationProducts(ASP),aleadingglobalinfect...uisitionbyitsFrenchaffiliate,ApsisS.A.S.,ofGloster...tionprocessesandtechnologiestopreventhealthcare-ac...osed. ,, GlosterEuropedesignsandmarketsaninnova...fectionofpatientenvironmentssuchashospitalandopera...
(Date:11/20/2009)...he United States Court of Appeals for the First C...terday, approving a settlement in the long-running...gation against AstraZeneca Pharmaceuticals ( AZN)..../20080317/AQM144LOGO ) ,, The ruling affirms a ...e pharmaceutical giant,s prostate cancer drug Zola...
(Date:11/20/2009)...ire/ -- The National Association of Drug Diversion...ative in the war on methamphetamine. The National...lectronic tracking program that enforces purchase ...ntaining pseudoephedrine in real-time at the point...system that was developed and tested in Kentucky i...
Breaking Medicine Technology:ASP Announces Acquisition of Gloster Europe to Help Reduce Infections in Healthcare Facilities 2U.S. Court of Appeals Upholds AstraZeneca AWP Settlement 2U.S. Court of Appeals Upholds AstraZeneca AWP Settlement 3National System Aims To Minimize Diversion of Cold and Allergy Medicine in Methamphetamine Production 2National System Aims To Minimize Diversion of Cold and Allergy Medicine in Methamphetamine Production 3Sedationfacts org Enhances State Specific Site Content Making Regional Sedation Administration Standards and Regulations Quick and Easy to Find and U 53876 1Sedationfacts org Enhances State Specific Site Content Making Regional Sedation Administration Standards and Regulations Quick and Easy to Find and U 53876 2Sedationfacts org Enhances State Specific Site Content Making Regional Sedation Administration Standards and Regulations Quick and Easy to Find and U 53876 3Sedationfacts org Enhances State Specific Site Content Making Regional Sedation Administration Standards and Regulations Quick and Easy to Find and U 53876 4deCODE genetics Announces Webcast of Conference Call to Discuss Second Quarter 2009 Financial Results 13422 1deCODE genetics Announces Webcast of Conference Call to Discuss Second Quarter 2009 Financial Results 13422 2Internists tackle key health reform issues 53870 1Internists tackle key health reform issues 53870 2Internists tackle key health reform issues 53870 3
...26, 2007 - Cytogen,Corporation (NASDAQ: CYTO) toda...or published at upcoming major medical meetings. T...lts for QUADRAMET(R),(samarium Sm-153 lexidronam i...t of metastatic bone disease arising from prostate... a study,evaluating the outcomes of prostate cance...
... Primary Endpoint of,In-Segment Late Loss, Non-Inf...sel Failure and Superiority in Major Adverse Cardi...BBOTT PARK, Ill., March 24, 2007 /PRNewswire-First... III U.S. pivotal clinical,trial at the of Cardiol...s demonstrated the following key results: , , -...
Other Medicine Technology:New Clinical Data for Cytogen's Quadramet and Prostacint to be,Reported at Upcoming Major Medical Meetings 2New Clinical Data for Cytogen's Quadramet and Prostacint to be,Reported at Upcoming Major Medical Meetings 3New Clinical Data for Cytogen's Quadramet and Prostacint to be,Reported at Upcoming Major Medical Meetings 4New Clinical Data for Cytogen's Quadramet and Prostacint to be,Reported at Upcoming Major Medical Meetings 5Abbott's Xience V Everolimus Eluting Coronary Stent Superior to,Taxus Stent in Spirit III U.S. Pivotal Clinical Trial 2Abbott's Xience V Everolimus Eluting Coronary Stent Superior to,Taxus Stent in Spirit III U.S. Pivotal Clinical Trial 3Abbott's Xience V Everolimus Eluting Coronary Stent Superior to,Taxus Stent in Spirit III U.S. Pivotal Clinical Trial 4Abbott's Xience V Everolimus Eluting Coronary Stent Superior to,Taxus Stent in Spirit III U.S. Pivotal Clinical Trial 5
iEMS Incubator/Shaker HT
Minimal M9 Broth
Agar Bacteriological grade
...s is available, ensuring the customers to find the...ic requirements. miniTHERM incubators have a capac...saving. Their size corresponds approximately to a ... to three units on top of each other. The units ha...
Medicine Products: